A New Target for Chronic Pain? BDNF’s Role in Neuronal Remodeling
A recent study in the Journal of Neurochemistry reveals a time-dependent mechanism by which Brain-Derived Neurotrophic Factor (BDNF) orchestrates the maturation of cortical neurons. The research demonstrates that BDNF accelerates the acquisition of a mature transcriptomic profile in developing neurons. Crucially, single-nucleus RNA sequencing identified a robust, cell-type-specific induction of Matrix Metalloproteinase 3 (MMP3), an enzyme involved in extracellular matrix remodeling, specifically within Lhx6-positive inhibitory interneurons. This finding suggests BDNF facilitates neural circuit development through targeted, cell-specific transcriptional changes.
Study Significance: This research on BDNF and MMP3 induction in inhibitory neurons provides a novel molecular framework for understanding central sensitization, a key mechanism in chronic neuropathic and inflammatory pain. For pain medicine specialists, it highlights a potential new pathway for therapeutic intervention. Targeting specific BDNF-mediated extracellular matrix changes could inform future strategies for interventional pain procedures and the development of non-opioid analgesics aimed at modifying maladaptive neural plasticity.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
